SEC Filing Details
Document Details
Form
Filing Date
Nov 20, 2018
Document Date
Nov 15, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Oramed Pharmaceuticals Inc.
Issuer
ORAMED PHARMACEUTICALS INC.
Filer
Hasleton Mark Daniel